Cordyceps cicadae Prevents Renal Tubular Epithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in Hypertensive Renal Injury

MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells

(2019) Yong Liu et al.   MOLECULAR THERAPY

O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats

(2018) Rodrigo Pacheco Silva-Aguiar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sirtuins in Renal Health and Disease

(2018) Marina Morigi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease

(2018) Yue Wang et al.   Journal of Translational Medicine

Mitochondrial Fission Is Required for Angiotensin II-Induced Cardiomyocyte Apoptosis Mediated by a Sirt1-p53 Signaling Pathway

(2018) Jia Qi et al.   Frontiers in Pharmacology

N6-(2-Hydroxyethyl) Adenosine From Cordyceps cicadae Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-β1/Smad and NF-κB Signaling Pathway

(2018) Rong Zheng et al.   Frontiers in Physiology

Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways

(2018) Dan Xiong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

P53 in kidney injury and repair: Mechanism and therapeutic potentials

(2018) Chengyuan Tang et al.   PHARMACOLOGY & THERAPEUTICS

Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: a potential risk to individuals with impaired kidney function

(2018) Shuyun Liu et al.   PHYTOMEDICINE

Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms

(2017) Teresa M. Seccia et al.   JOURNAL OF HYPERTENSION

H2S as a possible therapeutic alternative for the treatment of hypertensive kidney injury

(2017) George J. Dugbartey   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Biological characteristics, bioactive components and antineoplastic properties of sporoderm-broken spores from wild Cordyceps cicadae

(2017) Yanfang Sun et al.   PHYTOMEDICINE

SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis

(2016) Xue-ling Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Polydatin Protecting Kidneys against Hemorrhagic Shock-Induced Mitochondrial DysfunctionviaSIRT1 Activation and p53 Deacetylation

(2016) Zhenhua Zeng et al.   Oxidative Medicine and Cellular Longevity

p53 in survival, death and metabolic health: a lifeguard with a licence to kill

(2015) Flore Kruiswijk et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Tubular atrophy in the pathogenesis of chronic kidney disease progression

(2015) Jeffrey R. Schelling   PEDIATRIC NEPHROLOGY

Autophagy activation reduces renal tubular injury induced by urinary proteins

(2014) Wei Jing Liu et al.   Autophagy

P53 and Sirt1: Routes of metabolism and genome stability

(2014) Stefania Gonfloni et al.   BIOCHEMICAL PHARMACOLOGY

Nephrosclerosis: update on a centenarian

(2014) Alain Meyrier   NEPHROLOGY DIALYSIS TRANSPLANTATION

Apoptosis and angiogenesis: an evolving mechanism for fibrosis

(2013) Ariel Johnson et al.   FASEB JOURNAL

Ergosterol peroxide from Cordyceps cicadae ameliorates TGF-β1-induced activation of kidney fibroblasts

(2013) Rong Zhu et al.   PHYTOMEDICINE

SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function

(2012) Nathan L. Price et al.   Cell Metabolism

Introduction to Volume One: Atlas of Chronic Kidney Disease in the United States

(2011)   AMERICAN JOURNAL OF KIDNEY DISEASES

The controversial links among calorie restriction, SIRT1, and resveratrol

(2011) Yi Hu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway

(2011) Wang-bin Ning et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Hypertensive nephropathy: prevention and treatment recommendations

(2010) Peter D Hart et al.   EXPERT OPINION ON PHARMACOTHERAPY